CTRI/2022/06/043457尚未招募未知
To study the first pass success rate of ultrasound guided peripheral intravenous access in difficult intravenous access patients(DIVA) when compared to traditional methods with training in emergency care providers
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with difficult intravenous access coming to Emergency
排除标准
- •Patients with unstable vitals requiring immediate resuscitation
研究者
相似试验
进行中（未招募）
不适用
A phase I-IIa clinical study on the investigational anticancer drug J1 in patients with advanced cancer. A prospective, single armed, open label, dose-finding phase I-IIa study.Treatment of cancer.MedDRA version: 8Level: HLTClassification code 10029105EUCTR2005-002901-22-SEOncopeptides AB40
已完成
1 期
Salmonella vaccine study in OxfordISRCTN51750695niversity of Oxford31
已完成
1 期
A Clinical Study to know the safety, pharmacokinetics and anticancer activity of NRC-2694-A in patients with advanced cancersCTRI/2014/01/004293ATCO Pharma Limited26
终止
1 期
A first-in-human study of VG161 in participants with advanced malignant tumours that have not responded to conventional therapies.Advanced malignant solid tumorsCancer - Other cancer typesCancer - Any cancerACTRN12620000244909Virogin Biotech Australia Pty. Ltd.7
已完成
1 期
A clinical trial to test the safety of a herbal drug.CTRI/2017/11/010352SK Biolabs100